Forte Biosciences (FBRX) Income Statement: Revenue & Earnings

Forte Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Forte Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.04	0.00	0.00	0.00	0.00
Gross Profit	-0.04	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	21.19	21.86	5.59	13.85	10.00
Selling, General & Administrative	15.37	10.62	8.30	7.63	4.22
Operating Expenses	36.56	32.49	13.90	21.49	14.23
Operating Income	-36.60	-32.49	-13.90	-21.49	-14.23
Other Income/Expense
Interest Income	1.31	1.12	0.16	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	1.12	-0.11	-0.15	-0.22	-0.21
Income
Income Before Tax	-35.48	-31.48	-13.88	-21.71	-46.49
Income Tax Expense	0.00	0.00	-0.08	0.00	-3.25
Net Income	-35.48	-31.48	-13.88	-21.71	-46.49
Net Income - Continuous Operations	-35.48	-31.48	-13.88	-21.71	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-35.44	-32.48	-13.90	-21.45	-14.17
EBIT	-36.60	-32.49	-13.90	-21.49	-14.23
Depreciation & Amortization	0.04	0.01	0.04	0.04	0.05
Earnings Per Share
Basic EPS	-12.00	-25.00	-20.00	-39.00	-158.00
Diluted EPS	-12.00	-25.00	-20.00	-39.00	-158.00
Basic Shares Outstanding	2.92	1.26	0.70	0.56	0.29
Diluted Shares Outstanding	2.92	1.26	0.70	0.56	0.29